GSK Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2003
Net Income	4,484	4,928	14,956	4,385	5,749	4,645	Upgrade
Depreciation & Amortization	-91	0	0	0	0	2,334	Upgrade
Share-Based Compensation	-	0	0	0	0	365	Upgrade
Other Operating Activities	3,280	1,840	-7,553	3,567	2,692	676	Upgrade
Operating Cash Flow	7,673	6,768	7,403	7,952	8,441	8,020	Upgrade
Operating Cash Flow Growth	56.15%	-8.58%	-6.90%	-5.79%	5.25%	-4.76%	Upgrade
Capital Expenditures	-1,307	-1,286	-997	-818	-940	-1,170	Upgrade
Acquisitions	-2,127	-1,407	-3,225	154	24	-3,525	Upgrade
Change in Investments	2,989	2,001	96	58	2,857	-188	Upgrade
Other Investing Activities	-891	-903	-4,646	-1,171	220	-471	Upgrade
Investing Cash Flow	-1,336	-1,595	-8,772	-1,777	2,161	-5,354	Upgrade
Dividends Paid	-2,260	-2,247	-3,467	-3,999	-3,977	-3,953	Upgrade
Share Issuance / Repurchase	20	10	25	21	29	51	Upgrade
Debt Issued / Paid	-3,308	-2,567	-4,824	-2,184	-4,216	3,515	Upgrade
Other Financing Activities	-835	-837	9,089	-1,427	-1,968	-1,453	Upgrade
Financing Cash Flow	-6,383	-5,641	823	-7,589	-10,132	-1,840	Upgrade
Exchange Rate Effect	-87	-99	152	-29	-39	-82	Upgrade
Net Cash Flow	-46	-468	-546	-1,414	470	826	Upgrade
Free Cash Flow	6,366	5,482	6,406	7,134	7,501	6,850	Upgrade
Free Cash Flow Growth	64.16%	-14.42%	-10.20%	-4.89%	9.50%	-5.45%	Upgrade
Free Cash Flow Margin	20.71%	18.08%	21.85%	28.89%	30.80%	20.29%	Upgrade
Free Cash Flow Per Share	3.14	2.70	3.18	3.56	3.76	3.45	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).